Latest News in the pharma Industry

All

Insanitary conditions bring Isomeric Pharmacy Solutions to a halt

Insanitary conditions bring Isomeric Pharmacy Solutions to a halt

6 Aug 2017

Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions.

Read more 
AbbVie's Mavyret receives FDA approval for the treatment of chronic hepatitis C

AbbVie's Mavyret receives FDA approval for the treatment of chronic hepatitis C

6 Aug 2017

FDA approval is supported by an overall 98% cure rate in patients who received the recommended duration of treatment .

Read more 
Captek Softgel International acquires J+D Labs

Captek Softgel International acquires J+D Labs

6 Aug 2017

J+D Labs’ extensive experience manufacturing a wide-range of softgels, specialized tablets, capsules, and powder formulations complements Captek’s offerings.

Read more 
NICE approves Abraxane for pancreatic cancer

NICE approves Abraxane for pancreatic cancer

6 Aug 2017

Life-extending pancreatic cancer medicine to be made available immediately on the NHS.

Read more 
Lonza acquires Micro-Macinazione to create the leader in micronization capacity and capabilities

Lonza acquires Micro-Macinazione to create the leader in micronization capacity and capabilities

4 Aug 2017

Bolt-on acquisition adds value to other areas of Lonza’ business, including Health & Nutrition ingredients and excipients.

Read more 
The new KTP 590X rotary press sharpens Romaco Kilian’s effervescents profile

The new KTP 590X rotary press sharpens Romaco Kilian’s effervescents profile

4 Aug 2017

Romaco will additionally show Innojet process technology and Kilian services at POWTECH.

Read more 
BMS to acquire IFM Therapeutics to strengthen oncology pipeline focus on innate immunity

BMS to acquire IFM Therapeutics to strengthen oncology pipeline focus on innate immunity

4 Aug 2017

Gains full rights to IFM’s preclinical STING and NLRP3 agonist programs focused on enhancing the innate immune response for treating cancer.

Read more 
Biopharma stages a strong recovery over the first half even as M&A deals disappoint

Biopharma stages a strong recovery over the first half even as M&A deals disappoint

4 Aug 2017

EP Vantage releases half-year reviews of pharma & biotech and medtech performance.

Read more 
FDA grants Genentech’s Alecensa Priority Review

FDA grants Genentech’s Alecensa Priority Review

3 Aug 2017

Designation given for initial treatment of people with ALK-positive lung cancer.

Read more 
IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity

IDT launches first Cas9 enzyme that drastically reduces CRISPR off-target effects without significant loss of on-target activity

3 Aug 2017

The launch represents a major step towards therapeutic use of CRISPR.

Read more 
BMS receives FDA approval for Opdivo Injection for metastatic colorectal cancer

BMS receives FDA approval for Opdivo Injection for metastatic colorectal cancer

3 Aug 2017

Approval based on CheckMate -142, in which Opdivo demonstrated an objective response rate of 28% among patients who received prior treatment with a fluoropyrimidine, oxaliplatin, and irinotecan.

Read more 
UBM and Restec discontinue Russia partnership

UBM and Restec discontinue Russia partnership

2 Aug 2017

RESTEC to organise a stand-alone IPhEB exhibition in Russia from 2018 onwards.

Read more